NCT02181764View on ClinicalTrials.gov

A Study of KRN23 in Subjects With X-linked Hypophosphatemic Rickets/Osteomalacia

PHASE1CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

June 30, 2015

Study Completion Date

June 30, 2015

Conditions
X-linked Hypophosphatemic Rickets/Osteomalacia
Interventions
DRUG

KRN23

Single SC administration on day 1: 0.3, 0.6 and 1.0 mg/kg

Trial Locations (2)

Unknown

Tokyo

Seoul

All Listed Sponsors
lead

Kyowa Kirin Co., Ltd.

INDUSTRY

NCT02181764 - A Study of KRN23 in Subjects With X-linked Hypophosphatemic Rickets/Osteomalacia | Biotech Hunter | Biotech Hunter